313. DERM DRUGS: Monoclonal antibodies

Send me a derm question or story through text or voicemail! This is the last installment in our series of DERM DRUGS. Monoclonal antibodies are becoming an important tool in veterinary dermatology — but what are they, and how do they actually work? In this episode, we break down monoclonal antibody therapy in practical terms. We explain how these targeted treatments are designed to recognize and block specific molecules in the immune system, helping reduce itch in allergic dogs without broadly suppressing immunity. We discuss commonly used products like Cytopoint which targets IL-31, a key cytokine involved in pruritus. We also introduce the announcement of an upcoming (not yet released) product called Befrena, another monoclonal antibody therapy, and what we know about this therapy today. 00:00 – Intro 02:07 – What is a Monoclonal Antibody 03:18 – Cytopoint Basics 05:35 – Potential Side-Effects 06:33 – Befrena Basics 08:44 – Overview 09:22 – Outro

You can listen to 313. DERM DRUGS: Monoclonal antibodies online on Radio and Podcast. Open the player on this page to stream the available audio.

313. DERM DRUGS: Monoclonal antibodies is an episode from The Derm Vet Podcast by Ashley Bourgeois, DVM, Dip ACVD.

This episode is 9:51 long.

This episode was published on Feb 26, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Derm Vet Podcast when more episodes are available from the podcast feed.